These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1767147)

  • 21. [Quantitative and qualitative hemostatic changes in 373 patients with recurring venous thromboses].
    Marbet GA; Duckert F; Biland L; Widmer LK
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1505-6. PubMed ID: 4081679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality in hemostasis and thrombosis--part I.
    Favaloro EJ; Plebani M; Lippi G
    Semin Thromb Hemost; 2012 Sep; 38(6):549-52. PubMed ID: 22941783
    [No Abstract]   [Full Text] [Related]  

  • 23. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)].
    Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR
    Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial thrombosis in the course of nephrotic syndrome. Report of three cases].
    Ameur A; Zarzur J; el Khorassani M; Ouzeddoun N; Benyahia B
    J Mal Vasc; 1998 Feb; 23(1):13-6. PubMed ID: 9551349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acquired and inherited hypercoagulability among patients with cerebral venous thrombosis].
    Sánchez-Martín B; Grasa JM; Latorre A; Montañés MA; García-Erce JA; Torres M; Calvo MT; Giralt M
    Neurologia; 2002 Oct; 17(8):405-9. PubMed ID: 12396970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on hypercoagulable state. II. The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects.
    Izak G; Galewski K; Eyal Z
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):544-51. PubMed ID: 5590243
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality in hemostasis and thrombosis, part II.
    Lippi G; Plebani M; Favaloro EJ
    Semin Thromb Hemost; 2013 Apr; 39(3):229-32. PubMed ID: 23526142
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis.
    Squizzato A; Van Zaane B; Gerdes VE; Büller HR
    Semin Thromb Hemost; 2011 Feb; 37(1):41-8. PubMed ID: 21249603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory diagnosis of hemorrhagic and thrombotic disorders.
    Kottke-Marchant K
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):809-53. PubMed ID: 7961292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular-bed-specific hemostasis and hypercoagulable states: clinical utility of activation peptide assays in predicting thrombotic events in different clinical populations.
    Rosenberg RD
    Thromb Haemost; 2001 Jul; 86(1):41-50. PubMed ID: 11487031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
    Sie P
    Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of hemostasis in venous thromboembolism pathology].
    Gaussem P; Siguret V; Aiach M
    Ann Biol Clin (Paris); 1998; 56(1):49-56. PubMed ID: 9754222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of hemostatic risk factors in predicting arterial thrombotic events.
    Feinbloom D; Bauer KA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2043-53. PubMed ID: 16100033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity.
    Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
    Circulation; 2008 Sep; 118(13):1366-72. PubMed ID: 18779446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
    Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
    Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombosis and hypercoagulable states].
    Páramo JA; Cuesta B; Fernández J; Alfaro MJ; Paloma MJ; Rocha E
    Rev Med Univ Navarra; 1987; 31(4):233-7. PubMed ID: 3327132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.